Upsized and top-of-the-range: Fall round of biotech IPOs starts with a solid hit for Principia
Anyone considering a biotech IPO will want to pay close attention to the latest success story on Nasdaq.
Principia Biopharma raised $106 million from a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
